Programme:
BCP-UTI-01

Description:
BCP-UTI-01 is a first-in-class intravenous bacteriophage cocktail targeting carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in complicated urinary tract infections.

This programme is designed to address a critical unmet medical need in patients who have failed or cannot tolerate available antibiotic therapies.

Stage:
Preclinical development